Jefferies Financial Group’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Buy |
57,000
+2,000
| +4% | +$40.7K | 0.01% | 489 |
|
|
2025
Q1 | $998K | Sell |
55,000
-2,335,398
| -98% | -$42.4M | 0.01% | 627 |
|
|
2024
Q4 | $60.4M | Buy |
2,390,398
+2,369,398
| +11,283% | +$59.9M | 0.36% | 26 |
|
|
2024
Q3 | $714K | Buy |
+21,000
| New | +$714K | 0.01% | 659 |
|
|
2023
Q2 | – | Sell |
-3,000
| Closed | -$108K | – | 1230 |
|
|
2023
Q1 | $108K | Sell |
3,000
-20,000
| -87% | -$720K | ﹤0.01% | 997 |
|
|
2022
Q4 | $1.03M | Buy |
+23,000
| New | +$1.03M | 0.01% | 511 |
|